This website is intended for healthcare professionals

News

Statin prescribing practice

This article in the journal JAMA Cardiology presents the findings of a cluster randomised clinical trial involving 4131 patients from 28 primary care practices and 158 clinicians between October 2019...

Examining sustainable practice in prescribing

This article, published in the Journal of Medical Ethics, sought to identify the barriers to prescribing more environmentally friendly inhalers (Parker, 2023). One of the drivers for this article was...

Machine learning for precision treatment

Sotomi et al (2023) examine the use of machine learning to identify cohorts of a population that may benefit from specific medications. The team had previously established a machine learning-based...

Examining prescribing in children and adolescents

This cohort study, published in The Lancet Psychiatry journal, aimed to identify trends in antipsychotic drug prescribing to children and adolescents in England (Radojčić et al, 2023). This was driven...

Research to support diabetes remission in general practice

Diabetes UK (2023), together with the American Diabetes Association and the European Association for the Study of Diabetes, defines remission as HbA1c levels remaining below 48 mmol/mol or 6.5% for...

Prescribing during pregnancy

This article was published in BMC Medicine, used a retrospective cohort study approach to examine data between 2000 and 2019 (Subramanian et al, 2023). The author's main driver to conduct this...

Past the peak: navigating depression in the aftermath of COVID-19

Depression was already one of the commonest mental disorders in Great Britain, but new research has shown that the COVID-19 pandemic has resulted in an increase of mental distress in adults across the...

Cardiac effects of cancer therapy and what is being done about it

The drug doxorubicin slows or stops the spread of cancer cells by blocking the enzyme, topoisomerase, which cancer cells rely on for their division and growth (Cancer Research UK (CRUK), 2019). It is...

Long-term effects of COVID-19: impact on prescribing practice

This article provides follow-up guidance on patients with the most severe COVID-19 disease, namely, those that required critical care or had changes noted on chest x-ray consistent with COVID-19...

Antibiotic awareness and preventing further antimicrobial resistance

The development of antibiotics has been revolutionary for medicine and public health. However, given the resistance that is now building up against them, we are facing one of the most significant and...

Novel research into glucose-lowering drugs for heart failure shows promise

Alongside important lifestyle changes, first-line treatment for heart failure is an angiotensin-converting enzyme (ACE) inhibitor and a beta blocker licensed for heart failure in people with reduced...

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP